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Sialadenoma papilliferum of the bronchus: 
a rare tumour of salivary gland origin
Abstract
Sialadenoma papilliferum is a benign salivary tumour which rarely occurs in the bronchial tree. Up to now, only four cases of 
pulmonary papillary sialadenoma have been reported in the  literature.
We discuss the case of a male patient with an accidental finding of a middle lobe nodule. The patient underwent a minimally 
invasive anatomical resection of the lobe to remove the lesion; the postoperative course was regular, and he was healthy at the 
last follow-up. 
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Introduction
Sialadenoma papilliferum (SP) is a rare, 
benign, papillary salivary gland tumour, usual-
ly diagnosed as a white exophytic mass of the 
oral and maxillofacial region [1]. Since its first 
description in 1969 [2], less than 100 cases have 
been reported in the medical literature, and most 
of them are located in the palate. 
This paper aims to report the fifth case, to 
the best of our knowledge, of an SP involving the 
bronchial tree. 
Case description
A 66-year-old male was referred to our De-
partment for an incidental finding of a solitary 
pulmonary nodule of the middle lobe. The pa-
tient’s medical history included renal transplan-
tation two years earlier from a living donor due to 
renal failure from mesangial IgA deposits. Eight 
months after the transplantation, the man un-
derwent right nephrectomy of the native kidney 
due to a clear cell renal carcinoma in stage pT1a 
N0 M0. During the standard oncological follo-
w-up, a whole-body computed tomography (CT) 
scan showed a 12 × 13 mm solitary pulmonary 
nodule of the middle lobe (Figure 1) with fluoro-
deoxyglucose (18F-FDG) avidity (SUVmax 4.3) at 
the positron emission tomography (PET) (Figu-
re 2). A transbronchial biopsy was not feasible, 
and the CT-guided transthoracic biopsy was not 
diagnostic. Pulmonary function tests were regular. 
Therefore, we discussed the indication for surgery 
during the multidisciplinary oncological team 
meeting. A VATS middle lobectomy with systema-
tic lymphadenectomy through a biportal appro-
ach was performed. The postoperative period was 
uneventful, and the patient was discharged on the 
third postoperative day. After almost three years 
from surgery, he is healthy, with no recurrence.
Pathologically, at the gross examination of 
the resected lobe, a micro-cystic neoplasm of 
1.5 cm in diameter, was found close to the lobar 
bronchus.
Frozen sections showed a papillary and cy-
stic lesion with no sign of malignancy and the 
diagnosis was deferred.
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Figure 1. CT scan showing the middle lobe nodule
Figure 2. PET 18 F-FDG showing the contrast uptake of the nodule
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Histologically, the lesion was described as 
a cystic neoplasm, well-demarcated by a thin fi-
brous capsule, with cysts containing eosinophilic 
material or papillary structures lined by at least 
two layers of the epithelium (Figure 3). At immu-
nohistochemistry, neoplastic cells were negative 
for TTF1, Napsin A, Thyroglobulin, PAX8, and 
GATA3. The epithelial cells of the basal layer were 
positive at immunohistochemistry with p63 and 
ck14. The suprabasal layer was negative for 
p63 and only focally positive for ck14; it was often 
multi-layered, with some micropapillary tufts, 
and showed mild polymorphic hyperchromatic 
nuclei and rare prominent nucleoli. Furthermore, 
the cysts containing eosinophilic material were 
lined by the same layered epithelium that was ne-
gative for TTF1, Napsin A, Thyroglobulin, PAX8, 
and GATA3 as well. The lesion seems to originate 
from submucosal bronchial glands.
The described findings are consistent with 
a cystic papillary neoplasm of undetermined 
malignant potential (probably, low), most likely 
originating from bronchial glands. The final dia-
gnosis was sialadenoma papilliferum (SP), a rare 
subset of ductal papilloma of minor salivary gland 
origin, also described in the bronchi [3–5]. In 
our opinion, this tumour could be considered as 
a “salivary gland type bronchial neoplasm”.
Conclusion
Rare primary tumours of the lung account 
for less than 1% of all primary lung neoplasms 
and include a wide variety of cancers [6]. They 
usually present as a non-small cell lung cancer 
with symptoms related to their size, localisation, 
and malignancy (cough, dyspnoea, chest pain, 
haemoptysis, fever, fatigue, etc.). A tissue biopsy 
is often mandatory to make an accurate diagnosis, 
and surgery is still the most effective treatment, 
with chemotherapy and radiotherapy playing 
a role as adjuvant strategies.
Here, we present the fifth case of SP of the 
tracheobronchial tree published in the literature. 
A thorough search was performed in PubMed on 
December 1st, 2018, using the terms “lung”, “bron-
Figure 3. A., B. At low power, both cysts with blood and eosinophilic material (asterisks) and cysts with papillary projections are observed (blue 
square) (H&E, original magnification 100×); C., D. Papillary projections and cysts are lined by a luminal epithelium (luminal cells, red arrows) 
 showing pluristratification, anisonucleosis and nucleoli and a basal monostratified epithelium (basal or aluminal cells, black arrows) with a my-
oepithelial appearance (H&E, original magnification 400×)
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chial” and “sialadenoma/sialadenoma papillife-
rum” as keywords. Only four studies were found 
(one was written in German and was excluded). 
First described in 1969 by Abrams and Finck [2], 
SP is a benign, neoplasm of salivary gland origin 
which is named after its histological resemblance 
to syringocystadenoma papilliferum of cutaneous 
adnexal origin [7]. In the oral cavity, it appears as 
a white-coloured, exophytic, papillary lesion of 
the mucosa [1, 7]. In the three reports analysed, 
the macroscopic appearance is similar, being de-
scribed as a well-demarcated, white, papillary or 
verrucous, sessile to a pedunculated lesion of the 
trachea or the bronchus [3–5]. It shows a histo-
pathological biphasic growth with an exophytic 
papillary squamous component and a solid/cystic 
part. SP is slightly more common among males, 
with a male-to-female ratio of 1.6:1, mainly affec-
ting individuals > 50 years of age (mean standard 
± deviation 56.8 ± 15.5 years) [1]. SP has been 
reported in a variety of locations characterised 
by slow growth and a benign course, although 
few cases of recurrence have been documented 
[8]. A malignant transformation is still unique, 
although possible [7].
Besides, the cell of origin of SP is still con-
troversial, but this neoplasm is thought to arise 
from both the excretory duct cells and bronchial 
glands in the case of salivary gland tumours 
and tracheobronchial tree lesions, respectively 
[3]. According to the literature review [8], the 
recommended treatment is a conservative sur-
gical approach. In the three reported pulmonary 
cases, two anatomical resections were performed 
(a sleeve right upper lobectomy and a lower right 
lobectomy); in the third one, simple excision of 
the endotracheal mass was made. In all cases, 
patients have been free of disease for at least 
6 months after surgery.
In our case, we did not have a preoperative 
diagnosis: therefore, considering the mass as 
a malignant tumour and evaluating its locali-
sation, we performed a middle lobectomy. Our 
patient underwent a periodical follow-up CT scan 
due to the significant risk of recurrence of kidney 
malignancy under immunosuppression, and he 
is currently free of tumour.
In conclusion, we report the fifth case of 
SP occurring in the bronchus. The awareness 
of the existence of such rare lesions is essential 
for pathologists, and clinicians should keep in 
mind the possible occurrence of this intrabron-
chial exophytic tumoral lesion in the differential 
diagnosis. It is also mandatory to consider the 
chance, although improbable, of malignancy for 
these lesions. Undoubtedly, additional reports 
with longer follow-up are needed to demonstrate 
the most appropriate treatment of this very rare 
lesion. 
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